- Home
- CHNR vs ALBT Comparison
CHNR vs ALBT Comparison
Compare CHNR & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHNR | ALBT |
|---|---|---|
| Founded | N/A | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.0M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CHNR | ALBT |
|---|---|---|
| Price | $3.91 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.3K | ★ 673.9K |
| Earning Date | 05-15-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.16 | $0.21 |
| 52 Week High | $8.20 | $4.74 |
Technical Indicators
Market Signals| Indicator | CHNR | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 42.45 |
| Support Level | $3.60 | $0.21 |
| Resistance Level | $3.93 | $0.39 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 21.63 | 51.35 |
Price Performance
Historical ComparisonAbout CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is a technology driven company with a focus on developing products and services that serve growing consumer health and technology markets. Through its AI-driven subsidiary, the company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Its segments consist of a consumer health technology segment, through which it distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America; and an artificial intelligence content technology segment, through which it develops and commercializes an AI-driven, short-form video generation platform.